Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-07-27

FDA Approved: LITHIUM CARBONATE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved Rising Pharma Holdings, Inc.'s generic lithium carbonate under an original Abbreviated New Drug Application (ANDA) for use as a mood stabilizer in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lithium carbonate (Lithium carbonate)

Snippet

ORIG AP for LITHIUM CARBONATE (LITHIUM CARBONATE)